Login
Cosmetics retailer makes ASX debut
Baker McKenzie has acted for a cosmetics and health products company on its IPO and ASX-listing.
Emma Musgrave
Firm: Baker McKenzie (Mediland Pharm)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: Mediland Pharm has listed on the Australian Securities Exchange (ASX) and launched an IPO.
Value: $62.5 million
Area: Financial services
Key players: The Baker McKenzie team was led by head of financial services Bill Fuggle, with assistance from lawyer Amy Xi.
Deal significance: Founded in 2002, Mediland is a retailer that manufactures cosmetic and health products, as well as a selection of wool products and jewelry.
Over the past 16 years the company has parntered with major Chinese travel agencies and tour operations as part of its strategy to service the Chinese inbound tourism sector in Australia.
Mediland currently has stores in Sydney, Melbourne and the Gold Coast – all seeing significant foot traffic from Chinese tourists, according to a Baker McKenzie statement.
“We were delighted to act for our client, Mediland Pharm Limited, on what was a successful launch on the ASX,” the firm’s head of financial services Bill Fuggle said.
“The listing will assist the company [in raising] capital to expand their future operations.”
